Showing 1 - 4 results of 4 for search 'K. Wendland', query time: 0.02s Refine Results
  1. 1
    SU(2) channels the cancellation of K3 BPS states

    SU(2) channels the cancellation of K3 BPS states by A. Taormina, K. Wendland

    Published 2020-04-01
    Get full text
    Article
  2. 2
    P1314: PURIFICATION AND FUNCTIONAL CHARACTERIZATION OF CD34+ CELLS FROM CRYOPRESERVED APHERESIS PRODUCTS OF PATIENTS WITH BONE MARROW INFILTRATING MALIGNANCIES

    P1314: PURIFICATION AND FUNCTIONAL CHARACTERIZATION OF CD34+ CELLS FROM CRYOPRESERVED APHERESIS PRODUCTS OF PATIENTS WITH BONE MARROW INFILTRATING MALIGNANCIES by F. Muller, K. Wendland, S. Petkovic, J. Strobel, A. Mackensen

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins

    P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins by F Muller, F Gsottberger, S Petkovic, L Nitschke, A Mackensen, K Wendland

    Published 2024-03-01
    Article
  4. 4
    10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction

    10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction by F Muller, F Gsottberger, S Petkovic, A Mackensen, L Mellenthin, S Völkl, G Benintende, R Pelzl, K Wendland

    Published 2024-03-01
    Article

Search Tools: